Compare SAP SE (SAP) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SAP SE vs BIO-TECHNE Corp — how do they compare? SAP SE trades at $154.5 (market cap $183.83B), while BIO-TECHNE Corp trades at $71.63 (market cap $11.16B). The key difference: SAP SE is far larger — about 16.5× BIO-TECHNE Corp's market cap, and SAP SE pays the higher dividend (1.85%). Which is the better fit depends on your goals.
| SAP | TECH | |
|---|---|---|
Market Cap | $183.83B | $11.16B |
Sector | Technology | Health |
52-Week High | $307.27 | $72.12 |
52-Week Low | $148.06 | $43.31 |
Enterprise Value | $181.35B | $11.24B |
Dividend Yield | 1.85% | 0.45% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SAP SE
Founded in 1972 by former IBM employees, SAP provides database technology and enterprise resource planning software to enterprises around the world. Across more than 180 countries, the company serves 440,000 customers, approximately 80% of which are small to medium-size enterprises.
Read more on SAP →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
